1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency

Drug Use in Renal Insufficiency

136 - 150 of 199 Results
Sort Results:
Article: boxed warning about stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban) in atrial fib patients July 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
PL Voices: Managing the “Triple Whammy” Interaction April 2013
Commentary: The "Triple Whammy" April 2013
Article: kidney risks of NSAIDs April 2013
PL Voices: Combining ACEIs, ARBs, or Aliskiren (Tekturna) March 2013
Article: Does it ever make sense to COMBINE an ACEI with an ARB...or aliskiren (Tekturna) with an ACEI or ARB March 2013
PL Voices: Comparing the New Oral Anticoagulants February 2013
Article: approval of Eliquis (ELL-eh-kwiss, apixaban) will intensify the marketing war among the NEW oral anticoagulants February 2013
Chart: Colchicine Dosing and Drug Interactions December 2012
Commentary: Update on the Risk for Serious Bleeding Events with Pradaxa December 2012
Guideline: 2012 American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and Antiinflammatory Prophylaxis of Acute Gouty Arthritis December 2012
PL Voices: Strategies for Managing Gout December 2012
PL Voices: Managing Bleeding with Pradaxa (dabigatran) or Xarelto (rivaroxaban) December 2012